News

Moderna Inc. shares declined after the company’s first-quarter vaccine sales missed estimates and it disclosed a delay in the ...
The US Department of Health and Human Services announced the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine.
Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...
On a Thursday conference call with investors, Moderna CFO Jamey Mock outlined a roadmap for the mRNA specialist to lower its ...
Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...
Moderna logged a first-quarter loss as revenue fell, dragged down by lower product sales, though the company said it expects ...
On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...
Jefferies analysts said Moderna’s first quarter was “in line,” with a miss on revenue offset by a beat on earnings per share.
Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.
Moderna is once again expanding its cost-cutting measures as it seeks to rein in expenses and reach financial breakeven in ...
Moderna faces revenue declines, regulatory setbacks, and market challenges as COVID-19 vaccine demand wanes. Learn more about ...
Moderna, known for its COVID-19 vaccines, has been found guilty of 10 breaches of regulatory code after it marketed its ...